Letters
Role of spironolactone in heart failure should be emphasised
BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7262.706 (Published 16 September 2000) Cite this as: BMJ 2000;321:706
- James Mapstone, specialist registrar public health medicine (James.Mapstone@sessex-ha.nthames.nhs.uk),
- Brian Houston, general practitioner,
- Mike Gogarty, deputy director of public health (Mike.Gogarty@sessex-ha.nthames.nhs.uk)
- South Essex Health Authority, Brentwood CM13 3BE
- Highlands Surgery, Leigh on Sea SS9 2UT
- South Essex Health Authority, Brentwood CM13 3BE
EDITOR—We welcome the article by Lonn and McKelvie on drug treatment in heart failure,1 which is a common and important condition. The article showed how good the evidence on the subject is. We were disappointed, however, that the role of spironolactone in improving outcomes was not discussed.
A randomised controlled trial …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.